Levolin 2 Tablet contains Levosalbutamol 2 mg, a selective beta-2 adrenergic receptor agonist used primarily as a bronchodilator in the management of bronchospasm associated with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. By stimulating beta-2 receptors in the bronchial smooth muscle, Levosalbutamol promotes relaxation of airway muscles, leading to bronchodilation and improved airflow. This medication is indicated for the relief and prevention of bronchospasm, providing rapid onset of action to alleviate symptoms such as wheezing, shortness of breath, and chest tightness. Levolin 2 Tablet is typically administered orally and should be used as prescribed by a healthcare professional. It is important to adhere to the recommended dosage to minimize potential side effects, which may include tremors, headache, palpitations, and tachycardia. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or diabetes mellitus. Levolin 2 Tablet should not be used concurrently with non-selective beta-blockers as they may antagonize its effects. Regular monitoring and consultation with a healthcare provider are essential to ensure optimal therapeutic outcomes and to adjust treatment as necessary. This medication is intended for short-term relief and should be part of a comprehensive asthma or COPD management plan.